GLP-1 prescribing in the US may have reached a plateau, new data suggests.  Prescribing rates remained stable from June to September, according to an analysis of EHR data from researchers at Truveta — a platform that includes de-identified patient data…

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an Oct. 23 statement issued ahead of a hearing before the Senate…

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share where they see hospital consolidation going within the next five years. The 14 executives featured in this article are all speaking at the Becker’s Healthcare Spring…

The Institute for Safe Medication Practices has signed a contract with the FDA to assist in evaluating products and issue alerts about emerging drug safety issues.  The ISMP, a 501(c)(3) nonprofit organization focused on preventing medication errors, will collaborate with…

CVS Health has resolved a system outage that temporarily disrupted prescription processing at some of its pharmacy locations, according to an Oct. 21 report from CNN. The disruption arose Oct. 21 and affected patients seeking prescription pickups, flu shots and…

A  pharmacy has been fined $1 million by Pennsylvania’s Department of State and placed on probation for compounding and distributing tens of thousands of doses of injectable weight loss drugs in uninspected facilities. Kennett Square-based Boothwyn Pharmacy began producing GLP-1…

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection is indicated for short-term use — two to eight days — in…

Mark Cuban elaborated on how his online pharmacy, Cost Plus Drugs, will partner with TrumpRx during a CNBC interview at HLTH 2025 in Las Vegas. The Trump administration shared plans for TrumpRx in September. The federal website is set to…

Recently approved delays and exemptions to the CMS drug price negotiation program are projected to cost $8.8 billion over 10 years, according to a Congressional Budget Office report published Oct. 20.  CMS expanded orphan drug exclusions to its drug price…

The FDA is experiencing rising delays in drug approvals, raising concerns about operational strain within the agency, according to an RBC Capital Markets analysis. The Oct. 20 report, which was shared with Becker’s, found a sharp increase in missed action…